Lyell Immunopharma
LYEL16.8600.66% ( +0.110 )
已收盘: 11月11日 16:00:00 (美东)全部股东
股东类型
- 机构投资者36.47%
- 风投/私募35.02%
- 私营企业17.51%
- 个人与内部人士7.23%
- 公众及其他3.77%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
Arch Venture Partners, L.P. | 22.65% | 556.84 万 | 8.77% | +232.13 万 | |
Innovative Cellular Therapeutics Holdings Limited | 11.29% | 277.50 万 | 0.93% | -8.25 万 | |
Gates Frontier, LLC | 6.22% | 152.91 万 | 0.34% | +0 | |
Explore Investments LLC | 6.22% | 152.91 万 | 0.34% | +0 | |
GSK Equity Investments, Limited | 6.15% | 151.27 万 | 0.31% | +0 | |
Antonis Indianos | 5.80% | 142.65 万 | 0.31% | +0 | |
Mwg Management Ltd. | 4.10% | 100.81 万 | 0.22% | +0 | |
Vanguard Capital Management, LLC | 3.58% | 87.99 万 | 0.13% | +7.48 万 | |
Apoletto Limited | 3.07% | 75.47 万 | 0.17% | +0 | |
BlackRock, Inc. | 2.95% | 72.43 万 | 2.12% | +53.25 万 | |
Decheng Capital LLC | 2.81% | 69.21 万 | 0.15% | +0 | |
Almitas Capital LLC | 2.36% | 58.14 万 | 0.11% | +3,600.00 | |
Foresite Capital Management, LLC | 1.94% | 47.64 万 | 3.54% | -80.11 万 | |
Millennium Management LLC | 1.49% | 36.75 万 | 0.47% | -9.14 万 | |
Opaleye Management Inc. | 1.40% | 34.40 万 | 1.06% | +26.49 万 | |
venBio LLC | 1.37% | 33.77 万 | 0.07% | +0 | |
GV Management Company, LLC | 1.19% | 29.33 万 | 0.06% | +0 | |
Geode Capital Management, LLC | 1.12% | 27.46 万 | 0.21% | -3.60 万 | |
Richard KlausnerFounder & Executive Chairman | 0.78% | 19.06 万 | 0.72% | -15.80 万 | |
State Street Investment Management | 0.75% | 18.53 万 | 0.44% | +11.28 万 |